These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 17114492)

  • 1. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
    Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
    J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides.
    Gorden KK; Qiu XX; Binsfeld CC; Vasilakos JP; Alkan SS
    J Immunol; 2006 Nov; 177(10):6584-7. PubMed ID: 17082568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
    Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
    Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-thymidine oligonucleotides mediate activation of murine glial cells primarily through TLR7, not TLR8.
    Du M; Butchi NB; Woods T; Peterson KE
    PLoS One; 2011; 6(7):e22454. PubMed ID: 21811614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
    Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
    PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
    Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
    Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.
    Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL
    Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The covalent modification and regulation of TLR8 in HEK-293 cells stimulated with imidazoquinoline agonists.
    Rajagopal R; Waller AS; Mendoza JD; Wightman PD
    Biochem J; 2008 Jan; 409(1):275-87. PubMed ID: 17868034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
    Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
    Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in TLR7/8 activation between monocytes and macrophages.
    Eng HL; Hsu YY; Lin TM
    Biochem Biophys Res Commun; 2018 Feb; 497(1):319-325. PubMed ID: 29448098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
    Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
    Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
    Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
    J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14+ cells are required for IL-12 response in bovine blood mononuclear cells activated with Toll-like receptor (TLR) 7 and TLR8 ligands.
    Buza J; Benjamin P; Zhu J; Wilson HL; Lipford G; Krieg AM; Babiuk LA; Mutwiri GK
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):273-82. PubMed ID: 18789542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
    Lollo C; de Moraes Vasconcelos D; Oliveira LMDS; Domingues R; Carvalho GC; Duarte AJDS; Sato MN
    Clin Immunol; 2016 Aug; 169():121-127. PubMed ID: 27392462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity.
    Johnson TR; Rao S; Seder RA; Chen M; Graham BS
    Vaccine; 2009 May; 27(23):3045-52. PubMed ID: 19428918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
    Kuznik A; Bencina M; Svajger U; Jeras M; Rozman B; Jerala R
    J Immunol; 2011 Apr; 186(8):4794-804. PubMed ID: 21398612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.